117 related articles for article (PubMed ID: 33604757)
1. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
[TBL] [Abstract][Full Text] [Related]
2. Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides.
Lai P; Liu F; Liu X; Sun J; Wang Y
Front Immunol; 2023; 14():1270365. PubMed ID: 37790936
[TBL] [Abstract][Full Text] [Related]
3. CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.
Bhabha FK; McCormack C; Campbell BA; Lade S; Buelens O; Van Der Weyden C; Prince HM
Australas J Dermatol; 2023 May; 64(2):194-203. PubMed ID: 36892928
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
Montes-Moreno S
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.
Miyagaki T; Inoue N; Kamijo H; Boki H; Takahashi-Shishido N; Suga H; Shimauchi T; Kiyohara E; Hirai Y; Yonekura K; Takeuchi K; Sugaya M
Br J Dermatol; 2023 Oct; 189(5):612-620. PubMed ID: 37539944
[TBL] [Abstract][Full Text] [Related]
6. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA).
Stokke J; Tann A; El-Mallawany NK; Oschlies I
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101448. PubMed ID: 36907638
[TBL] [Abstract][Full Text] [Related]
8. Spatially Resolved Transcriptomes of CD30+-Transformed Mycosis Fungoides and Cutaneous Anaplastic Large-Cell Lymphoma.
Choi ME; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
J Invest Dermatol; 2024 Feb; 144(2):331-340.e2. PubMed ID: 37544586
[TBL] [Abstract][Full Text] [Related]
9. CD30 role in the progression of epithelial tumors?
Fernandez-Flores A
Am J Dermatopathol; 2010 May; 32(3):315. PubMed ID: 20182340
[No Abstract] [Full Text] [Related]
10. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
[TBL] [Abstract][Full Text] [Related]
11. QuPath Analysis for CD30+ Cutaneous T-Cell Lymphoma.
Cieslak C; Mitteldorf C; Krömer-Olbrisch T; Kempf W; Stadler R
Am J Dermatopathol; 2023 Feb; 45(2):93-98. PubMed ID: 36669072
[TBL] [Abstract][Full Text] [Related]
12. Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis.
Mark E; Kempf W; Guitart J; Pulitzer M; Mitteldorf C; Hristov A; Torres-Cabala C; Marchi E; Cropley T; Rodriguez Pinilla SM; Griffin T; Fernandez R; Pileri S; Pileri A; Tabanelli V; Borretta L; Subtil A; Plaza JA; Piris JAMA; Feldman AL; Cerroni L; Gru AA
Am J Surg Pathol; 2024 May; 48(5):501-510. PubMed ID: 38533681
[TBL] [Abstract][Full Text] [Related]
13. CD30-positive anaplastic large-cell lymphoma associated with mycosis fungoides after treatment with dupilumab.
Saad S; Ram-Wolff C; De Masson A; Jachiet M; Battistella M; Vignon-Pennamen MD; Rivet J; Michel L; Mourah S; Bagot M; Dobos G
Eur J Dermatol; 2022 Jul; 32(4):536-537. PubMed ID: 36301751
[No Abstract] [Full Text] [Related]
14. A Case-Based Review of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Felts C; Tjarks BJ
S D Med; 2022 Sep; 75(9):402-409. PubMed ID: 36881825
[TBL] [Abstract][Full Text] [Related]
15. Pediatric primary cutaneous anaplastic large-cell lymphoma with associated hypovitaminosis D.
Tung-Hahn E; Mogilevskiy V; Black E; Morgan M; Tung R
Arch Dermatol Res; 2023 Dec; 316(1):50. PubMed ID: 38108932
[TBL] [Abstract][Full Text] [Related]
16. DUSP22-IRF4 Rearranged CD30-Positive Primary Cutaneous Lymphoproliferative Disorder With Gamma/Delta Phenotype.
Fattah YH; Crasto D; Liu SS; Linhares Y; Kerdel F; Hanly A; Karai LJ
Am J Dermatopathol; 2023 Dec; 45(12):831-834. PubMed ID: 37883980
[TBL] [Abstract][Full Text] [Related]
17. Primary Cutaneous Anaplastic Large Cell Lymphoma-A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features.
Ortiz-Hidalgo C; Pina-Oviedo S
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627126
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes.
Gordon ER; Kwinta BD; Schreidah CM; Fahmy LM; Adeuyan O; Queen D; Trager MH; Magro CM; Geskin LJ
Leuk Lymphoma; 2024 Jan; 65(1):48-54. PubMed ID: 37861685
[TBL] [Abstract][Full Text] [Related]
19. Dermal xanthomatous infiltrates after brentuximab vedotin therapy in mycosis fungoides with large-cell transformation: A novel histologic finding.
Buchely N; Al-Rohil RN; Aung PP; Jour G; Torres-Cabala C; Prieto VG; Ivan D
J Cutan Pathol; 2018 May; ():. PubMed ID: 29806104
[TBL] [Abstract][Full Text] [Related]
20. TOX expression and role in CTCL.
McGirt LY; Degesys CA; Johnson VE; Zic JA; Zwerner JP; Eischen CM
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1497-502. PubMed ID: 27345620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
